HPV status was confirmed by E7 RT-PCR. We developed a novel amplicon-based next generation sequencing assay (HPV16-detect) to detect circulating HPV DNA.

The hybrid capture II (HCII) test is a nucleic acid hybridization assay, in which specimens that contain target DNA will hybridize with a specific HPV RNA probe.

Can a DNA Test for HPV Replace the Pap Smear? A new test for HPV has been cleared as way to screen for cervical cancer, but doctors are concerned that it doesn't do enough to protect younger women.

HPV DNA testing at baseline predicted progression to cervical intraepithelial neoplasia grade 3 at 18-year follow-up more accurately than Pap smear.

Circulating tumor tissue-modified viral HPV DNA detected through a new assay appeared associated with nodal disease burden among patients with HPV-positive oropharyngeal squamous cell carcinoma ...

A new study suggests an HPV DNA test could make cervical cancer screening more accessible to women in developing countries.

The predictive values of HPV testing were not calculated in this study; however, the clinical specificity of mRNA testing seems to be improved compared with HPV DNA testing.

To determine whether testing for DNA of oncogenic human papillomaviruses (HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we conducted a randomized trial comparing th ...

HPV-positive circulating tumor (ct)DNA after chemoradiation (CRT) for cervical cancer had an independent association with worse outcomes, suggesting potential as a biomarker to guide decision ...

PurposeTo determine whether plasma human papillomavirus (HPV) DNA predates clinical recurrence and compare its accuracy with 3-month fluorodeoxyglucose positron emission tomography (FDG-PET) in ...

There may be some changes coming to your routine gyno visits. Yesterday, the FDA approved a new HPV DNA test for women 25 and older, which can be used alone (without a Pap smear) to test for ...